These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
65 related items for PubMed ID: 3905555
1. Insulin receptor changes in type 2 diabetes after short term insulin treatment. Rizkalla SW, Weissbrodt P, Tchobroutsky G, Slama G. Horm Metab Res; 1985 Oct; 17(10):512-7. PubMed ID: 3905555 [Abstract] [Full Text] [Related]
2. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes. Pedersen O, Hjøllund E, Beck-Nielsen H, Richelsen B, Sørensen NS. Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067 [Abstract] [Full Text] [Related]
3. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp. Golay A, Defronzo RA, Thorin D, Jequier E, Felber JP. Diabete Metab; 1988 Jan; 14(4):443-51. PubMed ID: 3066652 [Abstract] [Full Text] [Related]
5. Effect of short- and long-term chlorpropamide therapy on oral glucose tolerance and erythrocyte insulin receptors in non-obese non-insulin dependent diabetes mellitus. el-Andere W, Lerario AC, Wajchenberg BL. Horm Metab Res; 1987 Jun; 19(6):257-63. PubMed ID: 3623414 [Abstract] [Full Text] [Related]
6. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. DeFronzo R, Deibert D, Hendler R, Felig P, Soman V. J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552 [Abstract] [Full Text] [Related]
7. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose. Clemmons DR, Moses AC, Sommer A, Jacobson W, Rogol AD, Sleevi MR, Allan G. Growth Horm IGF Res; 2005 Aug; 15(4):265-74. PubMed ID: 16005252 [Abstract] [Full Text] [Related]
8. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction. Van Gaal L. Verh K Acad Geneeskd Belg; 1989 Aug; 51(1):47-80. PubMed ID: 2800685 [Abstract] [Full Text] [Related]
9. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients]. Li M, Zhou J, Bo YQ, Lu W, Jia WP, Xiang KS. Zhonghua Yi Xue Za Zhi; 2008 Jun 24; 88(24):1679-82. PubMed ID: 19024537 [Abstract] [Full Text] [Related]
10. Insulin and IGF1 receptor function among type II diabetic responders and nonresponders to glyburide. Grunberger G. J Lab Clin Med; 1993 Apr 24; 121(4):555-61. PubMed ID: 8454937 [Abstract] [Full Text] [Related]
11. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M. Nutr Metab Cardiovasc Dis; 2006 Mar 24; 16(2):137-47. PubMed ID: 16487914 [Abstract] [Full Text] [Related]
14. Fasting and feeding variations of insulin requirements and insulin binding to erythrocytes at different times of the day in insulin dependent diabetics--assessed under the condition of glucose-controlled insulin infusion. Hung CT, Beyer J, Schulz G. Horm Metab Res; 1986 Jul 24; 18(7):466-9. PubMed ID: 3527928 [Abstract] [Full Text] [Related]
20. The erythrocyte insulin receptor response to either feeding or a short fast. McElduff A, Eastman CJ. Horm Metab Res; 1984 Jun 24; 16(6):275-8. PubMed ID: 6389294 [Abstract] [Full Text] [Related] Page: [Next] [New Search]